"Immunization Schedule" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Schedule giving optimum times usually for primary and/or secondary immunization.
| Descriptor ID |
D007115
|
| MeSH Number(s) |
E02.095.465.425.400.470 E05.478.550.545
|
| Concept/Terms |
Immunization Schedule- Immunization Schedule
- Immunization Schedules
- Schedule, Immunization
- Schedules, Immunization
|
Below are MeSH descriptors whose meaning is more general than "Immunization Schedule".
Below are MeSH descriptors whose meaning is more specific than "Immunization Schedule".
This graph shows the total number of publications written about "Immunization Schedule" by people in this website by year, and whether "Immunization Schedule" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 2 | 3 |
| 2005 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 2 | 2 |
| 2009 | 0 | 3 | 3 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 1 | 1 | 2 |
| 2014 | 0 | 2 | 2 |
| 2015 | 1 | 0 | 1 |
| 2016 | 2 | 4 | 6 |
| 2017 | 27 | 34 | 61 |
| 2018 | 23 | 48 | 71 |
| 2019 | 12 | 29 | 41 |
| 2020 | 2 | 11 | 13 |
| 2021 | 12 | 26 | 38 |
To return to the timeline, click here.
Below are the most recent publications written about "Immunization Schedule" by people in Profiles.
-
Two Doses of SARS-CoV-2 Vaccines Reduce Risk of Death Due to COVID-19 in Solid Organ Transplant Recipients: Preliminary Outcomes From a UK Registry Linkage Analysis. Transplantation. 2021 11 01; 105(11):e263-e264.
-
COVID-19 in Canada: Experience and Response to Waves 2 and 3. JAMA. 2021 Sep 28; 326(12):1145-1146.
-
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season. MMWR Recomm Rep. 2021 08 27; 70(5):1-28.
-
Immunogenicity of Low-Dose Prime-Boost Vaccination of mRNA Vaccine CV07050101 in Non-Human Primates. Viruses. 2021 08 19; 13(8).
-
SARS-CoV-2 immunogenicity in individuals infected before and after COVID-19 vaccination: Israel, January-March 2021. Epidemiol Infect. 2021 08 17; 149:e239.
-
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial. Lancet. 2021 09 04; 398(10303):856-869.
-
Immunogenicity of inactivated COVID-19 vaccines at different vaccination intervals. Hum Vaccin Immunother. 2021 10 03; 17(10):3310-3313.
-
Perimyocarditis following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male: a case report. BMC Cardiovasc Disord. 2021 08 04; 21(1):375.
-
Evaluation of the dose-effect association between the number of doses and duration since the last dose of COVID-19 vaccine, and its efficacy in preventing the disease and reducing disease severity: A single centre, cross-sectional analytical study from India. Diabetes Metab Syndr. 2021 Sep-Oct; 15(5):102238.
-
The effect of a single dose of BNT162b2 vaccine on the incidence of severe COVID-19 infection in patients on chronic hemodialysis: a single-centre study. Clin Exp Nephrol. 2022 Jan; 26(1):54-58.